Hartmannova Raztopina Braun

Hartmannova Raztopina Braun is an injectable electrolyte solution containing potassium chloride, sodium chloride, calcium chloride dihydrate, and sodium lactate. It is supplied as an isotonic intravenous infusion intended for fluid and electrolyte replacement. The product is manufactured for the EU market and is classified as a prescription‑only volume expander. Its formulation provides balanced concentrations of key ions to support extracellular fluid volume and acid‑base balance.

Hartmannova Raztopina Braun is used in clinical settings where rapid restoration of intravascular volume and electrolyte balance is required. It is commonly employed for fluid resuscitation and maintenance in a variety of patient populations.

- Fluid resuscitation in hypovolemic shock or severe dehydration. - Electrolyte replacement during acute losses from vomiting, diarrhea, or burns. - Perioperative fluid management to maintain hemodynamic stability. - Maintenance hydration for trauma or surgical patients during postoperative care. - Support of metabolic acidosis correction through lactate metabolism.

Adverse reactions to Hartmannova Raztopina Braun are generally infrequent, but monitoring for both common and serious events is recommended during intravenous administration.

Common: - Mild local irritation at the infusion site. - Transient hypernatremia or mild electrolyte shifts. - Slight increase in blood pressure due to volume expansion. - Nausea or mild discomfort during infusion. - Fever or chills related to infusion.

Serious: - Severe hyperkalemia leading to cardiac arrhythmia. - Acute pulmonary edema from rapid volume overload. - Anaphylactic or severe hypersensitivity reaction. - Metabolic alkalosis from excess lactate conversion. - Coagulopathy or clotting abnormalities in predisposed patients. - Calcium precipitation causing vascular occlusion.

When using Hartmannova Raztopina Braun, clinicians should assess patient-specific factors and observe standard infusion precautions to minimize risk.

- Verify electrolyte levels and renal function before initiation. - Adjust infusion rate in patients with heart failure or pulmonary edema risk. - Use caution in individuals with hyperkalemia or hypercalcemia. - Avoid rapid bolus administration unless specifically indicated. - Monitor blood pressure, heart rhythm, and fluid balance during therapy. - Consider pregnancy status; data on safety are limited. - Ensure compatibility with other IV solutions and medications.

Hartmannova Raztopina Braun may interact with certain drugs, affecting electrolyte balance or infusion compatibility.

Avoid: - Concurrent administration with potassium‑sparing diuretics that may raise serum potassium. - Co‑infusion with calcium‑containing solutions that could precipitate calcium chloride. - Use with high‑dose sodium bicarbonate in patients prone to hypernatremia.

Use with caution: - Concurrent IV antibiotics that require separate lines to prevent incompatibility. - Loop diuretics, as they may exacerbate electrolyte shifts. - Blood products, requiring monitoring of calcium and potassium levels.